Your browser doesn't support javascript.
loading
De novo systemic atypical hemolytic uremic syndrome in an ABO-incompatible living kidney transplant recipient with a novel pathogenic CFHR1 gene mutation successfully treated with eculizumab: a case report.
Li, Dawei; Wang, Wei; Chen, Ruoyang; Wen, Jiqiu; Zhang, Ming.
Affiliation
  • Li D; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
  • Wang W; Department of Nephrology, Shanghai Tenth People's Hospital, Shanghai, China.
  • Chen R; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
  • Wen J; National Clinical Research Center for Kidney Diseases, Jinling Hospital, Medical School of Nanjing University, Nanjing, China. wjqkidney@hotmail.com.
  • Zhang M; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China. drmingzhang@126.com.
J Nephrol ; 35(7): 1895-1899, 2022 09.
Article in En | MEDLINE | ID: mdl-35852773
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Atypical Hemolytic Uremic Syndrome Type of study: Diagnostic_studies Limits: Humans / Male / Middle aged Language: En Journal: J Nephrol Journal subject: NEFROLOGIA Year: 2022 Document type: Article Affiliation country: China Country of publication: Italia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Atypical Hemolytic Uremic Syndrome Type of study: Diagnostic_studies Limits: Humans / Male / Middle aged Language: En Journal: J Nephrol Journal subject: NEFROLOGIA Year: 2022 Document type: Article Affiliation country: China Country of publication: Italia